Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0IV0E
|
|||
Drug Name |
US8853215, 3
|
|||
Synonyms |
SCHEMBL631179; CHEMBL3644466; DISALCDEOIPUGE-UHFFFAOYSA-N; BDBM135825; US8853215, 3; 1-(2-tert-Butylphenyl)-4-(1H-imidazol-4-ylcarbonyl)piperazine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H24N4O
|
|||
Canonical SMILES |
CC(C)(C)C1=CC=CC=C1N2CCN(CC2)C(=O)C3=CN=CN3
|
|||
InChI |
1S/C18H24N4O/c1-18(2,3)14-6-4-5-7-16(14)21-8-10-22(11-9-21)17(23)15-12-19-13-20-15/h4-7,12-13H,8-11H2,1-3H3,(H,19,20)
|
|||
InChIKey |
DISALCDEOIPUGE-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Plasma retinol-binding protein (RBP4) | Target Info | Inhibitor | [1] |
Target's Patent Info | Plasma retinol-binding protein (RBP4) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Derivatives of N-acyl-N-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes. US8853215. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.